CEBM and BMJ logo

Evidence Live Blog

Trustworthy evidence or paid lip service?

24th July 2019

How do we consider diseases nowadays and how do we develop and interpret evidence on this? The questions was introduced in an earlier blog because Evidence-based medicine (EBM) does not

The evidence of what?

12th July 2019

Today, how do we consider diseases and how do we develop and interpret evidence on this? How does modern medicine actually consider interrelated medical fundamentals such as disease, diagnosis, risk factor, existential condition, and problem?

Research without journals?

11th July 2019

For supposedly clever people, we academics are complete mugs.  Not only do we give away our research for publishers to make a profit1, our institutions pay hefty subscriptions just to access it, or pay even more if we want to make it freely available.

Evidence-based medicine challenges in new anticancer drugs

10th July 2019

This social pressure for “unmet medical needs” is, in many times, used as an argument for faster drugs approvals pathways. Access to new technologies is important but a balance between access, the cost of clinical drug trials and ensuring robust evidence,  “relevant, replicable, and accessible to end users” is required.

‘First, do no harm’: the promise of new scientific metrics

9th July 2019

In the new era of evidence-based medicine, ‘newly qualified doctors must be able to apply scientific methods and approaches to medical research and integrate these with a range of sources of information used to make decisions for care’

Show your working: Is the way we write our papers fit for purpose?

8th July 2019

Despite advancement, the way we write and report the findings from our research hasn’t really changed all that much in this same 100-year time frame. The ‘IMRAD’ model of writing academic papers appeared in the mid 20th century, and still forms the backbone of how we write papers today.